Attention www.globalkeysolutions.net is now www.keypedia.com, read the full press release here.
KeyPedia LogoKeyPedia Icon
  1. Home
  2. /
  3. Records
  4. /
  5. Eir
  6. /
  7. Caribe Holdings (Cayman) Co. Ltd dba PuraCap Caribe
EIR
•Caribe Holdings (Cayman) Co. Ltd dba PuraCap Caribe•July 2, 2021

Caribe Holdings (Cayman) Co. Ltd dba PuraCap Caribe – FDA EIR, Jul 2, 2021

Record Details

An FDA inspection of Caribe Holdings (Cayman) Co. Ltd dba PuraCap Caribe, a human drug manufacturer in Dorado, PR, was conducted from June 15 to July 2, 2021. This comprehensive inspection, performed under the Drug Manufacturing Inspections compliance program, focused on Current Good Manufacturing Practices (21 CFR 210/211). The agency identified nine significant objectionable conditions, which were documented on Form FDA 483 and issued to Plant Manager Mr. David Fuster. Key violations included deficiencies in the written stability program, such as not testing drug products in their actual container-closure systems and initiating stability studies before completing quality control tests. Calibration procedures for laboratory instruments were inadequate, and laboratory control mechanisms were not consistently followed, evidenced by incomplete analytical record reviews and insufficient control over access to stability samples. Facilities were not maintained in a good state of repair, and equipment cleaning procedures were deficient. The firm also failed to maintain adequately defined areas for rejected materials, a recurrent observation. Lastly, annual product review procedures were not properly followed. Management acknowledged the observations and committed to providing a written response with corrective actions within fifteen business days. The FDA warned that these conditions could lead to legal sanctions.

Company
Caribe Holdings (Cayman) Co. Ltd dba PuraCap Caribe
Inspection date
July 2, 2021
Product type
drugs
Office
San Juan District Office
People
  • Marian E. Ramirez (investigator)
  • Ivis L. Negron Torres
View Company Profile

ID · 8908d0a2-6d37-439e-9352-0e727a87f3ff

Violation Codes10
FD&C Act 501(a)(2)(B)21 CFR 211.166(a)21 CFR 211.5821 CFR 21121 CFR 820.10021 CFR 21021 CFR 211.166(a)(4)21 CFR 211.42(c)(2)21 CFR 211.160(a)21 CFR 211.160(b)(4)

Full citation text and observation details available on the Dashboard.

Other documents for Caribe Holdings (Cayman) Co. Ltd dba PuraCap Caribe
  • 483 - 2021-07-02July 2, 2021

Your cart

Your cart is empty.

Browse public document pages and click Buy this document. We'll ask for your email at checkout, no account needed up front.

Browse documents

Discuss this record with AI

KeyPedia

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore Caribe Holdings (Cayman) Co. Ltd dba PuraCap Caribe
KeyPedia
Regulatory Data Transformed
Stay in the loop

KRA score changes, company updates and news. About monthly, unsubscribe anytime.

Contact
New York Office:
370 Jay Street 7th Floor
Brooklyn, NY 11201
Scranton Office:
Scranton Enterprise Center, Suite 217
201 Lackawanna Avenue
Scranton, PA, 18503
🇺🇸+1 917-789-5099
🇪🇺+48 532-447-507
info@keypedia.com
Quick Links
HomePlatform OverviewMedia
KeyPedia™ Lite
Browse HubDatabase DirectoryRecordsCompaniesOfficesPeopleCareersAbout UsFounding TeamMeet Our ExpertsPartners
Legal & Ethics
Privacy PolicyTerms of ServiceOur Values & MissionCode of Ethics & AI Policy
©2026 KeyPedia™ | Global Key Solutions Corp. All rights reserved.